Home / Leaderboard / Darwin Global Management Limited
Darwin Global Management Limited
Abhishek Trehan · Hedge Fund · Long/Short Equity
Darwin Global Management Limited is a Jersey-based investment management firm founded in 2020 by Dr. Abhishek Trehan. The firm focuses on the global life sciences sector, primarily targeting long-term investments in public biotechnology and pharmaceutical companies. Drawing on the founder's medical background and previous experience as head of healthcare investments at D. E. Shaw & Co., the firm employs a concentrated, research-driven strategy. It aims to identify high-conviction opportunities in companies developing disease-transforming therapeutics, often engaging in active monitoring of its portfolio holdings to ensure long-term value creation for its investors.
Simulated Performance
| Metric | Value |
|---|---|
| Total return | +2.8% |
| YTD return | -25.2% |
| Sharpe ratio | 2.62 |
| Win rate | 55% |
| AUM | $5.9B |
| Inception | Oct 1, 2025 |
| Updated | Nov 19, 2026 |
Institution Status
| Field | Value |
|---|---|
| AUM | $5.9B |
| Turnover | Low (<15%) |
| Avg holding | 18 Months |
| Inception | Oct 1, 2025 |
| Website | https://darwincap.com |
Current Holdings
Updated on Nov 19, 2026.
| Ticker | Name | Portfolio % | Return |
|---|---|---|---|
| GMAB | Genmab AS | 35.0% | +37.5% |
| RVMD | Revolution Medicines Inc | 34.0% | -17.7% |
| INSM | Insmed Inc | 12.2% | -14.5% |
| BLTE | Belite Bio Inc ADR | 7.8% | +38.8% |
| ABVX | Abivax SA American Depositary Shares | 6.7% | -7.4% |
| ROIV | Roivant Sciences Ltd | 4.3% | +24.6% |
Recent activity
| Date | Action | Ticker | Weight |
|---|---|---|---|
| Nov 2, 2026 | SELL | GMAB | 26.9% → 35.0% |
| Nov 2, 2026 | SELL | BLTE | 9.4% → 7.8% |
| Nov 2, 2026 | SELL | RVMD | 40.1% → 34.0% |
| Nov 2, 2026 | SELL | INSM | 12.7% → 12.2% |
| Nov 2, 2026 | BUY | ABVX | 6.3% → 6.7% |
Investment Style Analysis
Darwin Global Management Limited is widely recognized for employing a Long/Short Equity strategy. As of Nov 19, 2026, the firm oversees approximately $5.9B in assets under management (AUM). The portfolio demonstrates a clear preference for the Biotechnology sectors, reflecting a high-conviction approach to capital allocation.
Recent Market Moves
During the latest rebalancing period ending Nov 2, Darwin Global Management Limited made a significant move by reducing the position in GMAB. This adjustment aligns with the fund's dynamic approach to risk management and capital deployment in current market conditions.
Investment Philosophy
The core investment philosophy of Darwin Global Management is rooted in deep fundamental and scientific analysis of the biotechnology industry. The firm focuses on identifying companies with strong clinical data and the potential to launch disease-transforming drugs, believing that the market often undervalues the long-term potential of these innovations. With a background in medicine and pharmacology, the investment team applies scientific rigor to financial modeling, seeking to capture value from significant clinical or regulatory milestones. The firm maintains a patient, long-term perspective, resisting short-term volatility and opportunistic acquisitions that do not reflect a company's true intrinsic value.
Disclaimer
The content provided on this page, including the simulated portfolio performance, holdings analysis, and AI-generated insights, is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All data is derived from historical SEC 13F filings and other public disclosures, which have a reporting lag. The "Simulated Performance" is a hypothetical reconstruction based on past disclosures and does not represent the actual returns of the institution. Past performance is not indicative of future results. Tritonix.ai is not affiliated with Darwin Global Management Limited.
Similar Investment Style
Based on Long/Short Equity.
- Perceptive Advisors LLC — Joseph Edelman · 3M -17.7%
- Glenview Capital Management, LLC — Larry Robbins · 3M +2.2%
- Redmile Group, LLC — Jeremy Green · 3M -25.5%
- Theleme Partners LLP — Patrick Degorce · 3M +20.9%
Frequently asked questions
How is the simulated portfolio for Darwin Global Management Limited constructed?
This simulation is powered by Tritonix AI using official SEC filings. We focus on the "Best Ideas" by filtering for only the Top 20 largest holdings and rebalancing them to 100%. The simulation tracks performance starting from Oct 1, 2025. Our AI monitors for updates every Monday to capture major shifts. This concentrated approach highlights the manager's true stock-picking skill and mirrors their actual investment returns.
What is Darwin Global Management Limited's largest holding?
As of the latest filing, Darwin Global Management Limited's top position is Genmab AS (GMAB), representing 35.0% of the portfolio. This reflects a high-conviction bet by the institution.
What is Darwin Global Management Limited's historical performance and risk profile?
Our simulation indicates a total return of +2.8% with a win rate of 55%. Notably, the portfolio maintains a Sharpe Ratio of 2.62, suggesting an excellent level of risk-adjusted returns compared to the broader market.
What sectors does Darwin Global Management Limited primarily invest in?
Darwin Global Management Limited has a strong preference for the Biotechnology sector, which makes up 100.0% of their disclosed assets. The portfolio also has exposure to other industries, indicating a specific thematic focus.
Is Darwin Global Management Limited's portfolio concentrated or diversified?
Darwin Global Management Limited runs a highly concentrated portfolio with 6 disclosed positions. The top 3 holdings alone account for 81.2% of the total portfolio weight, suggesting a strategy that favors deep research into a few key names.
How has Darwin Global Management Limited performed in 2026?
Our AI-simulated model portfolio for Darwin Global Management Limited tracks a Year-to-Date (YTD) return of -25.2%. This metric helps investors gauge the institution's effectiveness in the current market environment.
Does Abhishek Trehan manage Darwin Global Management Limited directly?
Yes, Abhishek Trehan serves as the key portfolio manager for Darwin Global Management Limited, overseeing the investment strategy and final capital allocation decisions.